Marinus tanks as adult focal onset seizure drug fails late stage

(Reuters) – Marinus Pharmaceuticals Inc said it plans to stop development of its treatment for drug-resistant focal onset seizures in adults after it failed a late-stage trial, sending the company’s shares plunging 60 percent in premarket trading.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *